A Safety and Efficacy Follow-up Study With Levetiracetam in Children (4-17 Years Old) Suffering From Absence Seizures
Status:
Completed
Trial end date:
2003-05-01
Target enrollment:
Participant gender:
Summary
This long-term open label follow-up trial gave pediatric subjects suffering from typical
absences in CAE or JAE the opportunity to continue levetiracetam treatment after
participation in the pilot study (study N162) or the double-blind study (study N163). Safety
and efficacy data were obtained.